JPRN-UMIN000013628已完成未知
Telaprevir or simeprevir-based triple therapy for recurrent hepatitis C virus among living donor liver transplant recipients - TVR or SMV-based triple therapy for recurrent HCV among LDLT recipients
Hepato-Biliary-Pancreatic Surgery Division, and Artificial Organ and Transplantation Division0 个研究点目标入组 30 人开始时间: 2014年4月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •other than the above
研究者
相似试验
已完成
不适用
Telaprevir-based triple therapy significantly decreases the serum alpha-fetoprotein level in chronic hepatitis C patients: A prospective studyChronic hepatitis CJPRN-UMIN000013784Department of General Internal Medicine, Kyushu University Hospital200
已完成
不适用
The Effect of telaprevir-based triple therapy for chronic hepatitis C patients on gastric emptyingJPRN-UMIN000012279Chiba University30
已完成
不适用
The efficacy and safety of telaprevir-based triple therapy in elderly patients with HCV genotype 1 chronic hepatitis C, in comparison with the younger patientsChronic hepatitis CJPRN-UMIN000009711Kyushu University Hospital400
已完成
不适用
Effectiveness of simeprevir-based triple therapy for patients with telaprevir failureJPRN-UMIN000016205The Kyushu Univerisity Liver Disease Study Group30
进行中（未招募）
不适用
Study about human defence for chronic hepatitis C in patients who will be treated with telaprevir with peginterferon-alfa and ribaviriEUCTR2011-005636-26-NLFoundation for Liver Research25